Amicus Briefs
AdvaMed® submits amicus briefs on a variety of topics because of the strong interest and relevance to the medtech industry.
Legal
Learn more about our Legal work.
Mosby v. Ingalls Memorial Hospital (Illinois Supreme Court) April 27, 2023
The case involved expansive Biometric Privacy Act (BIPA) liability for medical device manufacturers. The device at issue was a medstation manufactured by BD that stores patient pharmaceuticals that can be…
Shining a Light On Litigation Financing: A Good First Step From GAO
Chris White, AdvaMed®’s General Counsel, explores the GAO’s recent report as “a welcome independent review raising attention to the need for disclosure and regulation of the litigation financing that fuels…
AdvaMed® Comments on the FTC’s Proposed Rule Banning Non-Compete Clauses in Contracts with Workers
AdvaMed, The Medtech Association®, recently commented on the FTC’s proposed rule that would ban employers from imposing or enforcing non-compete clauses in contracts with certain workers. AdvaMed® opposes the FTC’s vastly…
FTC’s Non-Compete Agreement Rulemaking Puts Medtech Innovation and Patient Access to New Treatments at Risk
The Federal Trade Commission published a proposed rule in the Federal Register that would, among other things, prohibit employers from imposing non-compete agreements on their employees.
AdvaMed® Asks Supreme Court to Protect Innovation in False Claims Act Case
AdvaMed, The Medtech Association®, asked the Supreme Court to affirm the judgments of the court of appeals in the Seventh Circuit in a significant case concerning the False Claims Act…
AdvaMed® Comment Letter to OIG – January 27, 2023
AdvaMed® responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
AdvaMed® Asks U.S. Supreme Court to Review Arbitrary and Excessive Punishments Resulting From Lack of Clarity in State Law
The Advanced Medical Technology Association® (AdvaMed®) asked the U.S. Supreme Court to review and reverse a California appeals court’s decision imposing over $300 million in penalties on a medical device…
AdvaMed® Asks U.S. Supreme Court to Affirm Government’s Authority to Dismiss Qui Tam Suits
The Advanced Medical Technology Association® (AdvaMed®) has asked the U.S. Supreme Court to affirm a Third Circuit decision that confirms the government’s right to dismiss qui tam suits under the…
AdvaMed® Files Amicus Brief with California Court Opposing New Liability Theory for Products in California Courts
AdvaMed® urged California’s First District Court of Appeal to overturn an erroneous decision by the trial court that has the potential to impose unfair and unwarranted liability upon companies that…